verified SJR 1 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Elsevier Inc.

workspace_premium Q1 — Cell Biology lock_open Open Access

Experimental Hematology

Experimental Hematology is a journal indexed in SJR in Cell Biology and Molecular Biology with an H index of 131. It has an SJR impact factor of 1 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.

Experimental Hematology focuses its scope in these topics and keywords: hematopoietic, marrow, factor, stem, bone, control, transcription, cells, cell, leukemia, ...

ISSN: 0301-472X

Publisher: Elsevier Inc.

Category: Cell Biology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1 Q1

H-index 131

Acceptance rate pie_chart

23% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

H-index

131

Docs (year)

Docs 3y

225

Total refs

5611

Cites 3y

501

Citable 3y

222

Cites/Doc 2y

1.92

Ref/Doc

66.01

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Effect of activated adherent cell conditioned medium on human CD34+ cell recruitment in short- and long term cultures

We Welcome a New Associate Editor

Fetal liver hematopoietic stem cells

Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukemia in patients over 60 years of age

Expression of CD41 on CD34+ primitive yolk sac hematopoietic progenitors

Ex vivo expansion of cord blood megakaryocytic cells

Epitope spreading occurs in cancer patients after vaccination with a single tumor antigen

Enhanced ability of myelopoietins, dual receptor agonists for human IL-3 and g-csf receptors and the IL-3 receptor agonist, daniplestim, to suppress apoptosis and stimulate cytokine-inducible gene expression

Endostatin induces tumor stabilization after chemo- or ANTI-CD20 therapy of high-grade non-hodgkin's lymphoma (Nhl)

Efficacy and safety of CD34-selected and CD19-depleted autografting in multiple myeloma patients A pilot study

Effects of anti-oxidants on normal and leukemic hematopoiesis

Effect of cryopreservation on adhesion molecule expression in peripheral blood derived CD34+ cells

SHOW MORE ARTICLES

Effect of combined INTERLEUKIN-1-alpha (IL1-A), Cyclophosphamide (Ctx) Treatment on hematopoietic stem cell function and numbers

A candidate cytokine gene selectively expressed in human CD34 + cells

Ebv-specific t-cell lines for adoptive transfer to pmrd allograft recipients

Does endogenous FLT3-ligand reflect impaired hematopoiesis in patients with b-lymphocytic chronic leukemia?

Cytokine treatment of hematopoietic stem/progenitor cells induces a homing defect in nonmyeloablated hosts

Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells

Cml patients with advanced phase disease retain clonogenic progenitor cells which are responsive to interferon alfa and STI571 in vitro

Ascorbic acid protects from activation of multiple caspases and of cytochrome c release induced by oxidative stress in human leukemia cells

Antiproliferative signaling of the cytokine receptor CD30 in the anaplastic large cell lymphoma cell line karpas 299

Allelic loss in hla class i expression is not a common event in acute leukemia

All-trans-retinoic acid inhibits the erythroid differentiation program of human marrow CD34+ progenitors

A novel minimized fixed-bed cultivation system for hematopoietic cells

FAQs

Experimental Hematology has an SJR of 1 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Experimental Hematology is 23%.

Experimental Hematology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Experimental Hematology?

What is the APC / publication cost?

What is the acceptance rate?